Penicillin or cephalosporin allergy in septic arthritis necessitates an alternative to cover Gram-negative bacilli; which agent is appropriate?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Penicillin or cephalosporin allergy in septic arthritis necessitates an alternative to cover Gram-negative bacilli; which agent is appropriate?

Explanation:
In septic arthritis, when the patient cannot receive beta-lactams due to penicillin or cephalosporin allergy, you want an antibiotic that provides reliable Gram-negative bacilli coverage without cross-reactivity concerns. Aztreonam fits this need because it is a monobactam with strong activity against Gram-negative organisms (including Pseudomonas) but no activity against Gram-positive bacteria or anaerobes. Importantly, it has minimal cross-reactivity with penicillins and cephalosporins, making it safe for patients with beta-lactam allergies while still delivering the necessary Gram-negative coverage. The other beta-lactams listed would pose a risk in a beta-lactam–allergic patient: the cephalosporin and penicillin-class drugs are associated with cross-reactivity, and the carbapenem also falls under beta-lactams with potential, albeit lower, cross-reactivity concerns. Therefore, aztreonam is the appropriate choice for covering Gram-negative bacilli in this scenario.

In septic arthritis, when the patient cannot receive beta-lactams due to penicillin or cephalosporin allergy, you want an antibiotic that provides reliable Gram-negative bacilli coverage without cross-reactivity concerns. Aztreonam fits this need because it is a monobactam with strong activity against Gram-negative organisms (including Pseudomonas) but no activity against Gram-positive bacteria or anaerobes. Importantly, it has minimal cross-reactivity with penicillins and cephalosporins, making it safe for patients with beta-lactam allergies while still delivering the necessary Gram-negative coverage.

The other beta-lactams listed would pose a risk in a beta-lactam–allergic patient: the cephalosporin and penicillin-class drugs are associated with cross-reactivity, and the carbapenem also falls under beta-lactams with potential, albeit lower, cross-reactivity concerns. Therefore, aztreonam is the appropriate choice for covering Gram-negative bacilli in this scenario.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy